Starpharma
Melbourne
About Starpharma
Starpharma Holdings Limited (ASX:SPL, OTCQX:SPHRY) is an ASX 300 company and is a world leader in the development of dendrimer products for pharmaceutical, life science and other applications. Starpharma’s underlying technology is built around dendrimers – a type of synthetic nanoscale polymer that is highly regular in size and structure and well suited to pharmaceutical and medical uses. Starpharma has three core development programs: VivaGel® portfolio, DEP™ drug delivery, and agrochemicals with the Company developing a number of products internally and others via commercial partnerships.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $32.2M
- Funding stage: IPO
- Last round: Post-IPO Equity (Sep 2020)
- Ticker: otcqx:SPHRY
- Website: starpharma.com
- Phone: +1 9897742322
Industries & Categories
Biotechnology, Manufacturing, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/starpharma-11965 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.